Bioanalytical insights into mediator lipidomics

Journal of Pharmaceutical and Biomedical Analysis
Kie KasugaNariyasu Mano

Abstract

The importance of lipids in health and disease has been widely acknowledged. Lipids are well known to undergo enzymatic and/or non-enzymatic conversions to lipid mediators (LMs), which demonstrate potent actions in various biological events, such as the regulation of cellular signaling pathways and the promotion and resolution of inflammation. LMs activate G-protein-coupled receptors (GPCRs) to exert various functions. Monitoring these mediators in disease is essential to uncover the mechanisms of pathogenesis for many diseases, such as asthma, rheumatoid arthritis, Alzheimer's disease, and cancer. Along with technical developments in mass spectrometry, highly sensitive and multiplexed analyses of LMs in the human periphery and other tissues have become available. These advancements enable the temporal and spatial profiling of LMs; therefore, the findings obtained from LM profiling are expected to decode pathology. As trace amounts of LMs can exert functions, the development of a highly sensitive, accurate, and robust analytical method is necessary. Although not mandatory, mediator lipidomics validation is becoming popular and remains challenging. Because LMs already exist in biological matrices, evaluations of the matrix effec...Continue Reading

References

Oct 10, 1986·Science·E Rozengurt
Feb 28, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·C M Chavez-EngB K Matuszewski
Jun 29, 2002·Cellular and Molecular Life Sciences : CMLS·J Z Haeggström, A Wetterholm
Oct 3, 2002·Nature Reviews. Immunology·Toby LawrenceDerek W Gilroy
Sep 5, 2003·Springer Seminars in Immunopathology·Paulo N RochaThomas M Coffman
Sep 30, 2003·Rapid Communications in Mass Spectrometry : RCM·Seon Hwa LeeIan A Blair
Dec 4, 2003·Biochimica Et Biophysica Acta·Michel LagardeFritz Spener
Mar 9, 2005·The Journal of Experimental Medicine·Makoto AritaCharles N Serhan
Aug 16, 2005·Prostaglandins & Other Lipid Mediators·Charles N Serhan
Feb 2, 2006·Journal of Lipid Research·Xianlin HanRichard W Gross
Sep 14, 2006·Pharmacological Reviews·Nan ChiangCharles Brink
Nov 14, 2006·Nucleic Acids Research·Manish SudShankar Subramaniam
Jan 5, 2007·Nucleic Acids Research·David S WishartLori Querengesser
Jan 24, 2007·The Journal of Experimental Medicine·Camilla I SvenssonCharles N Serhan
Feb 3, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Charles N SerhanJohn L Wallace
Apr 26, 2007·Journal of Lipid Research·Weiying YanMichael W Ogden
May 29, 2007·Nucleic Acids Research·Yuki MoriyaMinoru Kanehisa
Jun 23, 2007·Nucleic Acids Research·Eoin FahyShankar Subramaniam
Nov 27, 2007·Prostaglandins, Leukotrienes, and Essential Fatty Acids·T L GoodfriendA Vollmer
Feb 1, 2008·Annual Review of Pathology·Charles N SerhanRong Yang
Nov 11, 2008·Journal of Pharmaceutical and Biomedical Analysis·Mark B WilleyBradley L Ackermann
Nov 15, 2008·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Charles N Serhan
Feb 24, 2009·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Paolo Montuschi

❮ Previous
Next ❯

Citations

Sep 16, 2015·Journal of Clinical Medicine·Francesco Visioli
Oct 1, 2015·Pediatric Diabetes·Brigitte I Frohnert, Marian J Rewers
Mar 13, 2016·Pharmacology & Therapeutics·Maria Karmella ApayaLie-Fen Shyur
Oct 30, 2016·Trends in Biochemical Sciences·Kui Yang, Xianlin Han
Jan 12, 2019·Annual Review of Food Science and Technology·David C NiemanNicholas D Gillitt
Oct 18, 2019·The European Respiratory Journal·Howard H F TangMichael Inouye
Jun 21, 2019·Medicina·Oxana KytikovaTatyana Gvozdenko
Apr 7, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Masato NakajimaToshifumi Wakai
Sep 4, 2018·BioMed Research International·Yingrong ChenLicheng Dai
May 13, 2020·PPAR Research·Oxana Yu KytikovaTatyana A Gvozdenko
Sep 16, 2020·Journal of Sport and Health Science·David C Nieman, Brandt D Pence

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Related Papers

Inflammatory Bowel Diseases
Karsten H WeylandtDaniel C Baumgart
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
Michael PuppoloSusan A Jansen
© 2021 Meta ULC. All rights reserved